Company Search:
Advanced Search
Sponsored Links
Aslan Pharmaceuticals Ltd - ADR Company Snapshot
Aslan Pharmaceuticals Ltd operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Aslan Pharmaceuticals Ltd with three other companies in this sector in the United States: Albireo Pharma Inc (2016 sales of $11.36 million of which 100% was Pharmaceutical Indust), Chemocentryx Inc ($11.94 million of which 100% was Biopharmaceutical Company), and Novabay Pharmaceuticals, Inc. ($11.90 million ).

Sales Analysis.
  Stock Performance Chart for Aslan Pharmaceuticals Ltd - ADR
  Stock Data: Recent Stock Performance:
  Current Price (11/29/2019): 3.82
(Figures in U.S. Dollars)
1 Week 120.8%   13 Weeks 118.3%  
4 Weeks 130.1%   52 Weeks -25.0%  
Aslan Pharmaceuticals Ltd - ADR Key Data:
  Ticker: ASLN Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 11,578,479
(Year Ending Jan 2017).
Employees: N/A
  Currency: U.S. Dollars Market Cap: 122,430,236
  Fiscal Yr Ends: December Shares Outstanding: 32,049,800
  Share Type: American Depository Recei Closely Held Shares: 9,981,600
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.